|
HS Code |
174991 |
| Iupac Name | (S)-2-(Aminomethyl)-1-ethylpyrrolidine |
| Molecular Formula | C7H16N2 |
| Molecular Weight | 128.22 g/mol |
| Cas Number | 123334-89-6 |
| Appearance | Colorless to pale yellow liquid |
| Solubility In Water | Miscible |
| Chirality | S-enantiomer |
| Smiles | CCN1CCC[C@H]1CN |
| Inchi | InChI=1S/C7H16N2/c1-2-9-4-3-7(5-8)6-9/h7H,2-6,8H2,1H3/t7-/m0/s1 |
| Storage Temperature | 2-8°C |
| Purity | Typically ≥98% (assay by HPLC) |
As an accredited (S)-2-(Aminomethyl)-1-Ethylpyrrolidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A 25g amber glass bottle, tightly sealed, labeled "(S)-2-(Aminomethyl)-1-Ethylpyrrolidine, 98% purity," with hazard and handling instructions. |
| Shipping | (S)-2-(Aminomethyl)-1-Ethylpyrrolidine is shipped in sealed containers under ambient or refrigerated conditions, depending on stability requirements. Packaging ensures protection from moisture and light. All shipments comply with relevant chemical transport regulations, including labeling and documentation. Handle and store according to MSDS guidelines, and ensure compliance with local, national, and international shipping laws. |
| Storage | (S)-2-(Aminomethyl)-1-Ethylpyrrolidine should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizing agents. Keep it away from direct sunlight and moisture. Recommended storage temperature is 2-8°C (refrigerated), and the chemical should be clearly labeled. Use appropriate personal protective equipment when handling. |
Applications of (S)-2-(Aminomethyl)-1-Ethylpyrrolidine in Industrial Manufacturing(S)-2-(Aminomethyl)-1-Ethylpyrrolidine serves as a specialized chiral building block that supports core downstream processes within pharmaceutical synthesis, agrochemical development, and advanced material research. Below, we deliver clear application information for several major sectors with confirmed industrial adoption, detailing actual compliance requirements, targeted formulation advice, key integration points in production, and the end product profiles manufactured by our direct customers. 1. Chiral Pharmaceutical Intermediate – API SynthesisThe molecule’s asymmetric center and secondary amine make it a critical intermediate in the preparation of enantiomerically pure pharmaceutical actives, especially in the synthesis of β-lactam antibiotics and targeted CNS medicines. Many pharma partners specify controlled use in their patented drug pathways to establish stereochemical fidelity, reduction of impurities, and quality-driving batch production. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Advanced Agrochemical SynthesisWithin agrochemical production, this raw material provides a unique chiral foundation for the assembly of selective pesticide and herbicide actives, where configurational purity directly governs biological selectivity and regulatory acceptance in crop protection formulations. Its use is aligned with scalable process safety and environmental monitoring practices. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Peptidomimetic and Small Molecule Drug DiscoveryContract research organizations and innovative biotech companies employ this compound as a core chiral auxiliary or building block in peptidomimetic libraries, especially for classes targeting GPCRs and kinases. Here, the material’s well-defined stereochemistry and reactivity facilitate selective library assembly and enhance the druggability of lead structures. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fine Chemicals for Specialty CatalystsCatalyst manufacturers select this specialty amine as part of proprietary ligand systems for asymmetric catalysis in organic transformations, enabling precise induction of chirality in downstream high-value chemical productions. Controlled use supports the production of ligands and complexes critical for pharmaceutical and specialty polymer applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Research-Grade Analytical StandardsAnalytical labs and OEM instrument companies incorporate this compound as a certified reference material and system suitability standard for the qualification of chiral chromatographic methods. Its application secures traceable calibration, routine system checking, and the development of reliable test protocols for QC laboratories worldwide. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (S)-2-(Aminomethyl)-1-Ethylpyrrolidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In our operations, batch after batch, (S)-2-(Aminomethyl)-1-Ethylpyrrolidine always reminds us what rigorous standards mean in the fine chemicals industry. Our crew pays close attention right from choosing the starting materials. Only enantiomerically pure intermediates land in our reactors. We never pull shortcuts when it comes to stereochemistry. That single difference in chirality makes all the difference for scientific teams depending on consistency run after run. Once the synthesis gets underway, we apply nitrogen protection, keep everything moisture free, and control reaction temperatures to stay within a few degrees. Our analytical team tracks every stage with HPLC and chiral column chromatography, making sure we don’t let impurities pile up.
Once isolated, this compound stands apart because its amine group stays highly accessible. Its single chiral center drives the bioactivity that our pharmaceutical partners need. Many research groups look for this structural motif, since the aminomethyl group can connect with a range of molecular scaffolds during drug development. Lab managers and chemists want batch certificates that show no racemization, no excess water, and well-controlled residual solvents. We know that better than anyone, because sometimes we need to troubleshoot recrystallization conditions just for a more crystalline, free-flowing product. That time investment saves headaches for whoever’s setting up the next reaction downstream.
Any chemical manufacturer can issue a set of specs. For us, each lot gets its own test record—enantiomeric purity always north of 99%, colorless to pale yellow oil that pours easily and doesn’t gum up vials even after storage. With an eye on NMR and IR data, we always confirm that there’s no trace of previous batch contamination. Our people see to it that every shipment reflects this model—no two drums ever vary more than a fraction of a percent in composition or appearance.
Customers seldom realize what really goes into that level of reliability, unless they’ve run their own pilot lines and seen the importance of purity firsthand. On occasion, we’ve encountered requests for bulk modification: for instance, varying concentration in solution, or adjusting packaging for inert atmosphere transfer. We’ve adapted our process with custom container purging and nitrogen headspace drying to minimize moisture pickup during filling.
Looking back over years of production, feedback from clients working in both scale-up and research shows that consistently high enantiomeric purity matters as much as the apparent cleanness of the sample on a TLC plate. We have held samples for stability checks beyond a year, just to prove that our process beats the industry average shelf life. For those developing APIs, that reliability lets them progress to animal studies or GMP work without fear of batch-to-batch variation.
From our vantage, one of the key reasons customers reach out for (S)-2-(Aminomethyl)-1-Ethylpyrrolidine traces straight to its performance as a chiral building block. There are only a handful of other compounds that bring this particular combination of reactivity and selectivity. The chiral secondary amine finds its way into drug candidates for neurological, cardiovascular, and oncological applications.
Teams interested in peptidomimetics or CNS-targeted molecules know that minor tweaks to the side chain can tilt a drug’s whole profile toward better targeting. Our product’s clean amine lets research chemists jump straight to subsequent coupling, alkylation, or Boc-protection. No need to re-purify, no need to waste time on salt swaps.
Some years back, a biotech firm asked us to help with asymmetric transformation after their commercial supply introduced unwanted side products. Their synthetic route required the absolute configuration of the (S)-enantiomer for a specific GABA analog series. By ramping up analytical controls and reworking purification, our team delivered material that helped them nail their proof-of-concept study. That’s what we mean when we talk about impact—it’s not just about making molecules, it’s about enabling discovery on tight timelines.
Small-scale medicinal chemistry groups and process chemistry divisions alike prefer a source that delivers consistently. We’ve heard firsthand from researchers who lost weeks trying to troubleshoot a surprising drop in biological activity, only to find a supplier’s racemic batch had crept in. Our own priority has always been monitoring for even trace enantiomeric impurities.
More than a few companies offer pyrrolidine amines, but not all of them put the same care into synthetic control, packing, and real-world usability. Research-grade pyrrolidines with racemic mixtures can’t match the enantioselectivity that modern drug design demands.
In our facility, we avoid generic shortcuts like simply resolving racemates. We apply fully asymmetric synthesis, which brings higher chiral integrity than post-synthetic separations. The market also sees unloaded or diluted batches, visible as haze or off-odor right out of the drum. Our approach catches those deviations from the start, with both in-process testing and batch sample reserves for follow-up.
We’ve compared our (S)-2-(Aminomethyl)-1-Ethylpyrrolidine against library stocks and seen how shoddy purification can leave behind ghost peaks in chromatography, jeopardizing scale-up. For colleagues facing regulatory filings, clean documentation with batch tracking means they have less to explain to auditors. Anyone who has had a submission delayed by questionable certificate data knows the cost, both in time and credibility.
Structurally, this molecule’s combination of aminomethyl and 1-ethyl substitution puts it in a separate class from most alkylated or N-protected pyrrolidines. Researchers notice a marked difference in reactivity, kinetic profile, and selectivity during subsequent transformations—differences that matter in enzyme active site studies or receptor interactions for drug discovery. The free-flowing, high-purity oil that leaves our site stands apart in terms of both purity and performance.
Some lessons you only learn by making enough batches—and hearing what happens on the customer’s end. In our time making (S)-2-(Aminomethyl)-1-Ethylpyrrolidine, we’ve worked through questions of peroxide formation, trace halide residues from reaction workups, and the stability of both raw and finished product under different storage scenarios. One batch that picked up moisture from atmospheric transfer led us to overhaul our fill lines and storage tank seals—a lesson in never underestimating tiny sources of contamination.
Those problem-solving cycles don’t just keep our products cleaner—they let our team predict and prevent issues before a single gram ships out. As chemical manufacturers, we test stability not just at manufacture but also through simulated shipping, running temperature cycling to catch early breakdown or phase changes. We’ve supplied to both big pharmaceutical firms and nimble biotech startups, so we know every user sees different challenges with scale, storage, and automation.
Through ongoing feedback, we’ve upgraded our handling protocols. For example, direct end-user comments about bottle cap liner breakdown prompted us to source liners resistant to amines and switch to higher clarity bottles that simplify sample inspection. Researchers who receive our material aren’t stuck with cloudy, off-spec samples. We always include full spectral data and trace past releases to spot subtle trends. By benchmarking each lot, patterns emerge that reveal a need for process tweaks. That mindset leads to higher overall confidence and lower project risk for everyone down the line.
We respect the fact that our clients work under varying regulatory environments. Some need audit trails showing exactly how every gram was produced. Others must demonstrate impurity levels fall far beneath threshold limits. Our lot records detail each step so customers don’t end up scrambling for compliance checks at the last minute.
On the safety side, responsible handling starts with clear labeling and packaging, but also includes the right container size. Labs with modest throughput avoid waste using smaller aliquots, while larger operations get drum loads with spill-resistant closures. We recommend cold storage for maintaining optimal shelf life and always run stability tests under light, heat, and moisture exposure.
No one in the business today can ignore supply chain ups and downs. Global events, raw material shifts, and stricter audits mean we build in redundancies at every step. Early on, we experienced a bottleneck with a key resolving agent, leading us to bring several under our own quality system and keep safety stock. Now, we work with vetted suppliers and always keep backup intermediates on hand.
To reduce lot-to-lot variation, we refined our batch protocols and implemented rigorous statistical controls. Chromatography benches now have tighter controls on solvent quality, and our staff stay sharp on detecting off-characteristics during every stage of isolation. These investments cut down the likelihood of out-of-spec batches making it to packaging. Any outlier gets flagged and retested before release.
Sometimes a client faces an urgent deadline and calls for expedited supply. We built a flexible scheduling system into our production calendar, with capacity set aside for rush requests. Our logistics team collaborates closely with shippers to avoid customs delays and mismatched temperature storage, reducing surprises en route.
As manufacturers, we don’t just ship and forget. We welcome direct feedback and technical questions about (S)-2-(Aminomethyl)-1-Ethylpyrrolidine. Teams often reach out for advice on solvent compatibility, secondary functionalization, or post-coupling workups. That ongoing conversation helps us, too, because advances in downstream chemistry sometimes require us to tweak how we formulate, purify, or even package our product.
We’ve sponsored pilot research with academic labs to push new reaction protocols and test compatibility with next-generation catalysts. These collaborations open up new application spaces and keep us at the forefront of synthetic technique. When someone hits a snag—solubility limits, subtle impurities, or problems scaling up—a quick consult saves days or weeks of troubleshooting. Sharing our in-house results, including NMR and mass spec trace analysis, often solves issues before they escalate.
Making (S)-2-(Aminomethyl)-1-Ethylpyrrolidine isn’t just another project on our line—it represents the intersection of fundamental laboratory skill, advanced process engineering, and genuine collaboration between manufacturer and end user. Every improvement in purity, packaging, or logistics carries forward, giving researchers more certainty in their own experiments.
Any successful chemical manufacturer knows this class of compound brings special challenges. Every time we receive exceptional feedback, it’s proof that old-fashioned craftsmanship, well-trained teams, and modern analytical controls still matter. We understand the stakes for teams racing to develop the next important therapy or breakthrough tool. By continuing to refine our approach and challenge our standards, we help our clients stay focused where it matters—on scientific progress, not on housekeeping or crisis management.